Baltimore (PROTEXT) - In conjunction with GuilfordPharmaceuticals Inc. (Nasdaq: GLFD) Third Quarter earningsrelease, you are invited to listen to a replay of its conferencecall with Dr. Craig Smith, President and CEO of GuilfordPharmaceuticals. The...

Zadavatel:

PARADISE VALLEY, Ariz. (PROTEXT) - MW Medical, Inc., a NevadaCompany, (the "Company") announces that on October 25, 1999, vialetter, the United States Department of Health and HumanServices, Food and Drug Administration, granted the Companyapproval...

Zadavatel:

NEW YORK (PROTEXT) - Standard & Poor's will make the followingchanges in the S&P Euro and S&P Euro Plus Indices after the closeof trading Friday, October 29, 1999: -- Promodes S.A. will be deleted from both the S&P Euro andthe...

Zadavatel:

COLLEGEVILLE, Pa., and ANTONY, France (PROTEXT) - Rhone-Poulenc Rorer (RPR), the global pharmaceutical subsidiary ofRhone-Poulenc S.A. (NYSE: RP), announced that the Committee forProprietary Medicinal Products (CPMP) recommended approval ofTaxotere(R)...

Zadavatel:

SCHAUMBURG (USA) 27. října(PROTEXT/ots) - Zurich U.S., přednípojišťovna majetku a škod, dnes oznámila nový produkt pojištěnípolitických rizik u transakcí na kapitálovém trhu, napříkladumisťování soukromých akcií na trhu a emisí obligací v souladu sPředpisem...

Zadavatel:

Ingelheim, Germany (PROTEXT) - Study results show the AIDSdrug VIRAMUNE(R) (nevirapine, NVP) added to a combination therapyof zidovudine (ZDV) + lamivudine (3TC) suppressed HIV for up toone year in patients with advanced HIV disease and high baselineviral...

Zadavatel:

SALT LAKE CITY (USA) 25. října (PROTEXT) - Společnost Nu SkinEnterprises a její dceřiná společnost Pharmanex oznámily, že sestávají oficiálními sponzory zimních olympijských her v Salt LakeCity v roce 2002 a sponzory amerického olympijského týmu až doroku...

Zadavatel:

SALT LAKE CITY (USA) 25. října (PROTEXT) - Společnost Nu SkinEnterprises a její dceřiná společnost Pharmanex oznámily, že sestávají oficiálními sponzory zimních olympijských her v Salt LakeCity v roce 2002 a sponzory amerického olympijského týmu až doroku...

Zadavatel:

Ingelheim, Germany (PROTEXT) - Data Presented on ProteaseInhibitor-Sparing Trials and HIVNET 012 Study for the Preventionof Mother-to-Child HIV Transmission. A distinguished panel of HIV researchers presented results ofthree important VIRAMUNE...

Zadavatel:

RESEARCH TRIANGLE PARK (N.C.) 21. října (PROTEXT/ots) -Quintiles Transnational Corp. (Nasdaq: QTRN) dnes oznámil čistýpříjem za třetí čtvrtletí 1999 ve výši 457,8 miliónu USD, což jeo 26,5 procenta více než čistý příjem 362 miliónů USD za třetíčtvrtletí...

Zadavatel:

PHILADELPHIA (PROTEXT) - Hemispherx Biopharma, Inc. (Amex:HEB, HEBws) today announced that a major European country, forthe first time in European Union (EU) history, had formallyrecognized Chronic Fatigue Syndrome (CFS) as a severe chronicdisease...

Zadavatel:

FORT COLLINS, Colo. (PROTEXT) - Heska Corporation (Nasdaq:HSKA), a leader in companion animal health care products andservices, today reported its financial results for the thirdquarter ended September 30, 1999. Total revenue increased 33 percent...

Zadavatel:

PRAHA 18. října (PROTEXT) - Podle nových dat získaných zajeden rok, která byla prezentována na 12. kongresu ECNP (12thEuropean College of Neuropsychopharmacology), léčba přípravkemARICEPT (donepezil HCl) významně zlepšuje funkční schopnostpacientů s mírnou...

Zadavatel:

ATLANTA, and VANCOUVER, British Columbia (PROTEXT) - For thefirst time in any leading peer-review medical journal, theOctober issue of Archives of Ophthalmology published extensivepositive results from Phase III clinical trials involvingVisudyne (verteporfin...

Zadavatel:

CHICAGO (PROTEXT) - FMC Corporation today reported thirdquarter sales from continuing operations of $1 billion, comparedwith $1.1 billion in the 1998 quarter. Net income per share on adiluted basis was $1.98, including one-time gains from the salesof...

Zadavatel:

Reading, Pa. (PROTEXT) - Patients at risk under anesthesia cansignificantly lower their chances of developing extensivecomplications with the help of a new application of ultrasound.Called the HemoSonic(TM) 100, this noninvasive, powerful toolprobes...

Zadavatel:

Reading, Pa. (PROTEXT) - Patients at risk under anesthesia cansignificantly lower their chances of developing extensivecomplications with the help of a new application of ultrasound.Called the HemoSonic(TM) 100, this noninvasive, powerful toolprobes...

Zadavatel:

DALLAS (PROTEXT) - Researchers at Harvard Medical SchoolReplicate Controlled Clinical Trial Findings in Study of RoutinePractice Researchers from Harvard Medical School have found that use ofBispectral Index(R) (BIS(R)) monitoring in routine practiceenables...

Zadavatel:

PHILADELPHIA (PROTEXT) - Hemispherx Biopharma, Inc. (Amex:HEB; HEBws) today announced that it was developing clinicalprograms with Anderson Clinical Research that are designed toaddress the growing problem of multi-drug resistance found inbattling...

Zadavatel:

DALLAS (PROTEXT) - Technology Utilized in at Least 49Abstracts on Diverse Clinical Topics Researchers from 12 countries are presenting studies aboutBispectral Index(R) (BIS(R)) monitoring at the annual meeting ofthe American Society of Anesthesiologists...

Zadavatel: